Astrazeneca Pharma India Ltd (ASTRAZEN):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Astrazeneca Pharma India Ltd (ASTRAZEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3385
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company that discovers, develops, and commercializes medicines. The company offers products in the therapeutic areas of cardiovascular and metabolic diseases, respiratory, maternal healthcare, oncology, infection, neuroscience, and gastrointestinal. Its cardiovascular and metabolic disease products include candesartan cilexetil, ticagrwlor, exenatide, rosuvastatin, felodipine, metoprolo succinate, pramlintide acetate, and atenolol, among others. AstraZeneca offers oncology products such as anastrozole tablets, tamoxifen tablets, gefitinib tablets, goserelin acetate injection, goserelin acetate depot injection, bicalutamide tablets, and fulvestrant injection. The company operates in China, Hong Kong, India, Singapore, Thailand, Canada, Chile, Colombia, Mexico, the US, and Mauritius, among others. AstraZeneca is headquartered in Bangalore, Karnataka, India.

Astrazeneca Pharma India Ltd (ASTRAZEN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Sun Pharma Enters into Co-Marketing Agreement with AstraZenceca Pharma for Dapagliflozin 10
Sun Pharma Enters into Distribution Agreement with Astrazeneca Pharma 11
Dr Reddy’s Labs Enters into Distribution Agreement with Astrazeneca Pharma 12
Asset Transactions 13
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 13
Acquisition 14
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 14
Astrazeneca Pharma India Ltd – Key Competitors 15
Astrazeneca Pharma India Ltd – Key Employees 16
Astrazeneca Pharma India Ltd – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
May 09, 2017: AstraZeneca Pharma India Reports Total Income From Operations Of INR5.4 Billion In Fiscal 2017 18
Corporate Communications 19
Aug 08, 2017: AstraZeneca Appoints Mr. Ian John Parish to its Board of Director 19
Jun 29, 2017: AstraZeneca Announces Board Change 20
Other Significant Developments 21
May 17, 2018: AstraZeneca strengthens innovation partnership in India 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Sun Pharma Enters into Co-Marketing Agreement with AstraZenceca Pharma for Dapagliflozin 10
Sun Pharma Enters into Distribution Agreement with Astrazeneca Pharma 11
Dr Reddy's Labs Enters into Distribution Agreement with Astrazeneca Pharma 12
Zydus Cadila Healthcare May Acquire 8 brands from Astrazeneca India 13
AstraZeneca To Acquire Remaining 10% Stake In Astrazeneca Pharma India 14
Astrazeneca Pharma India Ltd, Key Competitors 15
Astrazeneca Pharma India Ltd, Key Employees 16

List of Figures
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Astrazeneca Pharma India Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Astrazeneca Pharma India Ltd (ASTRAZEN):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Decibel Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Decibel Therapeutics Inc (Decibel) is a hearing company that offers discovery, development and commercialization of new medicines for the treatment of hearing disorders. The company offer drugs for pediatric cancer and cystic fibrosis patients who experience ototoxicity or hearing loss. It p …
  • Syros Pharmaceuticals Inc (SYRS):企業の財務・戦略的SWOT分析
    Summary Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company that develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company offers its pipeline products under clinical trials include SY-1425, an oral, potent and selective RARa agonist that …
  • CAE Inc (CAE):企業の財務・戦略的SWOT分析
    CAE Inc (CAE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Air Liquide SA (AI):企業の財務・戦略的SWOT分析
    Air Liquide SA (AI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ctrip.com International, Ltd.:企業の戦略・SWOT・財務情報
    Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ctrip.com International, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • University of Oxford:企業のM&A・事業提携・投資動向
    University of Oxford - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Oxford Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Mostostal Warszawa SA (MSW):企業の財務・戦略的SWOT分析
    Mostostal Warszawa SA (MSW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Epax Norway AS:戦略・SWOT・企業財務分析
    Epax Norway AS - Strategy, SWOT and Corporate Finance Report Summary Epax Norway AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Larsen & Toubro Infotech Ltd (LTI):企業の財務・戦略的SWOT分析
    Larsen & Toubro Infotech Ltd (LTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Galilee Energy Ltd (GLL):石油・ガス:M&Aディール及び事業提携情報
    Summary Galilee Energy Ltd (Galilee) is a mining and minerals exploration and development company that offers exploration and development services. The company acquires, explores, produces, and develops coal seam gas in the Galilee Basin near Longreach in Queensland. It offers projects such as ATP79 …
  • PureCircle Ltd:企業の戦略・SWOT・財務情報
    PureCircle Ltd - Strategy, SWOT and Corporate Finance Report Summary PureCircle Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Golden Grain Energy, LLC:企業の戦略的SWOT分析
    Golden Grain Energy, LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Avivagen Inc (VIV):企業の財務・戦略的SWOT分析
    Summary Avivagen Inc (Avivagen), is a biotechnology company that provides drug development and animal healthcare products. It offers OxC-beta an active ingredient used to support the innate immune system and a healthy inflammatory condition of living beings. Avivagen's oxidized carotenoids promote a …
  • William Hill plc (WMH):企業の財務・戦略的SWOT分析
    William Hill plc (WMH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Jordan Phosphate Mines Co. Plc.:企業の戦略・SWOT・財務情報
    Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report Summary Jordan Phosphate Mines Co. Plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • Singapore Telecommunications Ltd (Z74):企業の財務・戦略的SWOT分析
    Singapore Telecommunications Ltd (Z74) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Cleveland BioLabs, Inc.:企業のM&A・事業提携・投資動向
    Cleveland BioLabs, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cleveland BioLabs, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary AGL Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆